The nation’s leading experts presented final influenza vaccine coverage data from the 2019-2020 season and discussed the importance of vaccination in order to prevent flu and pneumococcal disease at the 2020 NFID Influenza/Pneumococcal Disease News Conference on Thursday, October 1, 2020. NFID also shared results from a new national survey of US adults to better understand attitudes and behaviors about COVID-19, influenza, and pneumococcal disease.
Panelists for the event included Anthony S. Fauci, MD, of the National Institute of Allergy and Infectious Diseases, NFID Medical Director William Schaffner, MD, NFID President Patricia N. Whitley-Williams, MD, of Rutgers Robert Wood Johnson Medical School, cardiologist Federico M. Asch, MD, of MedStar Health Research Institute and Georgetown University, and Daniel B. Jernigan, MD, MPH, representing the Centers for Disease Control and Prevention.
National Survey: Attitudes about Influenza, Pneumococcal Disease, and COVID-19
Influenza Vaccine Coverage by Population
Influenza (Flu) Resources
Influenza Vaccine Options 2020-2021 Season
Myths and Facts about Influenza
The Dangers of Influenza and COVID-19 in Adults with Chronic Health Conditions
Leading By Example: NFID initiative calling on leaders in healthcare, business, education, and politics to lead by example by making a commitment to flu prevention. Organizations can join the growing list of supporters and participate in activities to show their support of annual flu vaccination.
Pneumococcal Resources
Understanding Pneumococcal Disease
Pneumococcal PSA: What Do They All Have In Common?
2020-2021 NFID Influenza/Pneumococcal Disease Awareness Campaign Final Report
